HPV is a significant risk factor for anal cancer, with 90% of cases linked to the virus. Awareness of symptoms is crucial for early detection. Support systems, including family and community ...

Advances in technology transforming the approach to prostate cancer: Dr Likhiteswer Pallagani: Shardul Nautiyal, Mumbai ...

CHAD Thompson grappled with a silent problem for 20 years – he couldn’t pee properly, and it was a constant source of anxiety ...

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private ...

Despite Charles’s welcome openness about his cancer, polls show declining support for the monarchy. To survive, the royals now need to lift the curtain on their finances, says academic Anna Whitelock ...

A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells could ...

Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Researchers identify APOC1 and NOP16 as promising prostate cancer biomarkers that could aid early diagnosis. Learn more about ...

Nigeria records over 18,000 new prostate cancer cases annually, accounting for the highest cancer burden among men in the country.

A Guisborough man's friend who died from prostate cancer ultimately saved his life after prompting him to push for tests.

Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks ...